Early-onset type 2 diabetes: High risk for premature diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 94, Issue 2, 2011, Pages 207-211

  Song, Soon H ^a   Gray, Trevor A ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Early onset; Premature; Retinopathy; Type 2 diabetes

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA BASE; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HOSPITAL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREDICTION; PREVALENCE; REGISTER;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENGLAND; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 81255160706     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.07.030     Document Type: Article

References (16)

1. Congdon N., Friedman D.S., Lietman T. Important causes of visual impairment in the world today. JAMA 2003, 290:2057-2060.
2. National Institute for Health and Clinical Excellence Type 2 diabetes. The management of type 2 diabetes. NICE Clinical Guideline 2009, NICE, London.
3. Fagot-Campagna A., Knowler W.C., Pettit D.J. Type 2 diabetes in Pima Indian children: cardiovascular risk factors at diagnosis and 10 years later. Diabetes 1998, 47(Suppl. 1):A155.
4. Hillier T.A., Pedula K.L. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003, 26:2999-3005.
5. Kohner E.M., Stratton I.M., Aldington S.J., Turner R.C., Matthews D.R. Microaneurysms in the development of diabetic retinopathy (UK Prospective Diabetes Study Group). Diabetologia 1999, 42:1107-1112.
6. Yokoyama H., Okudaira M., Otani T., Takaike H., Miura J., Saeki A., et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 1997, 20:844-847.
7. Okudaira M., Yokoyama H., Otani T., Uchigata Y., Iwamoto Y. Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes. J Diabetes Complications 2000, 14:281-287.
8. Eppens M.C., Craig M.E., Cusumano J., Hing S., Chan A.K., Howard N.J., et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006, 29:1300-1306.
9. Scott A., Toomath R., Bouchier D., Bruce R., Crook N., Carroll D., et al. First national audit of the outcomes of care in young people with diabetes in New Zealand: high prevalence of nephropathy in Maori and Pacific Islanders. N Z Med J 2006, 119:U2015.
10. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010, 363:233-244. The ACCORD Study Group and ACCORD Eye Study Group.
11. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. United Kingdom Prospective Diabetes Study Group.
12. Matthews D.R., Stratton I.M., Aldington S.J., Holman R.R., Kohner E.M. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Opthalmol 2004, 122:1631-1640.
13. Harris M.I. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993, 16:642-652.
14. Department of Health. Putting prevention first. Vascular checks: risk assessment and management. London: DH; 2008.
15. Sjolie S., Klein R., Porta M., Orchard T., Fuller J., Parving H.H., et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 2008, 372:1385-1393.
16. Keech A.C., Mitchell P., Summanen P.A., O'Day J., Davis T.M.E., Moffitt M.S., et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007, 370:1687-1697.